Connection
Michael Clay to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Michael Clay has written about Antibodies, Monoclonal, Humanized.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.108 |
|
|
|
-
Clay MR, Iberri DJ, Bangs CD, Cherry A, Jensen KC. Clinicopathologic characteristics of HER2 FISH-ambiguous breast cancer at a single institution. Am J Surg Pathol. 2013 Jan; 37(1):120-7.
Score: 0.077
-
Hoppmann A, Williams AP, Coleman A, Tynes C, Williams GR, Mroczek-Musulman E, Aye J, Whelan KF, Clay MR, Ranganathan S, Beierle EA. Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features. Pediatr Blood Cancer. 2020 02; 67(2):e28048.
Score: 0.031